A lipid nanocarrier small enough to pass the blood-brain barrier could be an effective method for delivering chemotherapy medications to help fight glioblastoma brain tumors, a new study reports.
Researchers have discovered a key to glioblastoma tumor cells proliferation, and ways to turn this engine of tumor growth into a target for cancer treatment.
A new nanocarrier meets the size and stability to effectively pass the BBB and deliver drugs to glioblastoma multiforme brain cancer.
Researchers report they have discovered an innovative method that may stop the spread of glioblastoma multiforme.
Newly released map of glioblastoma brain cancer could help researchers find new cures for deadly disease.
According to a new study, neural activity can stimulate the growth of high-grade glioma brain cancers.
Brain cancer cells resist therapy by temporarily losing gene mutations targeted by drugs, but re-amplify the mutation once the treatments have stopped, a new study reports.
A novel therapeutic, which is based on nanotechnology, turns off a critical gene and increases survival rates in mice with glioblastoma brain cancer, a new study reports.
Researchers delve deeply into the genomics of 599 GBM brain cancer cases to better target the disease.
Researchers discover a way to adjust the malignancy of glioma brain cancer cells in a newly developed 3D hydrogel. The new material mimics the conditions in the brain.
Researchers have developed a new approach for treating glioblastoma brain cancer. The findings are shown to extend the life of animals treated for the cancer.
A new drug could help increase the effectiveness of radiation therapy for patients with glioblastoma multiforme, the most deadly form of brain cancer. The ATM kinase inhibitor, in combination with radiation therapy, helped significantly extend survival rates in mouse models of GBM.
